A Loeliger
- Hematology top 5%
- Hemophilia Treatment and Research 7
- Blood Coagulation and Thrombosis Mechanisms 5
- Virology top 5%
- HIV Research and Treatment 4
- Internal Medicine top 10%
- Infectious Diseases top 10%
- HIV/AIDS Research and Interventions 4
- HIV/AIDS drug development and treatment 3
- Tuberculosis Research and Epidemiology 1
- Rheumatology top 10%
-
- Blood properties and coagulation 2
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- F KollerF DuckertJ. HersSylvia M. BruistenPeter ReissCharles A. BoucherAnn DuerrMina C. Hosseinipour
- Cited by
- HematologyVirologyInternal Medicine
- Partner nations
- NetherlandsSwitzerlandUnited States
In The Last Decade
A Loeliger
21 papers receiving 510 citations
Peers
Comparison fields: 5 of 75
- Hematology 234
- Virology 81
- Internal Medicine 35
- Infectious Diseases 120
- Rheumatology 93
Countries citing papers authored by A Loeliger
This map shows the geographic impact of A Loeliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Loeliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Loeliger more than expected).
Fields of papers citing papers by A Loeliger
This network shows the impact of papers produced by A Loeliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Loeliger. The network helps show where A Loeliger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Loeliger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 15 | |
| 2 | 2011 | 28 | |
| 3 | 2008 | 51 | |
| 4 | 1998 | 21 | |
| 5 | 1997 | 22 | |
| 6 | 1993 | 20 | |
| 7 | 1992 | 8 | |
| 8 | 1991 | 8 | |
| 9 | [Inadequate thrombokinase control & the quality of long-acting coumarin therapy]. | 1958 | 1 |
| 10 | 1957 | 18 | |
| 11 | [Fibrinogen deficiency with hemorrhagic diathesis associated with metastasizing melanoma]. | 1957 | 2 |
| 12 | [Thrombocytopenic purpura in three cases of drug allergy]. | 1954 | 1 |
| 13 | [Hemophilia B; two cases of hereditary hemophilia due to a deficiency of a new clotting factor (Christmas factor)]. | 1953 | 6 |
| 14 | 1953 | 11 | |
| 15 | [Demonstration of a new factor in blood coagulation: factor VII]. | 1952 | 2 |
| 16 | 1952 | 12 | |
| 17 | [Factor VII; its role in coagulation; its clinical importance]. | 1952 | 4 |
| 18 | [Determination of a new coagulation factor; factor VII]. | 1951 | 1 |
| 19 | 1951 | 231 | |
| 20 | 1951 | 4 |
About A Loeliger
A Loeliger is a scholar working on Hematology, Virology, Infectious Diseases, Rheumatology and Emergency Medicine, having authored 22 papers that have together received 617 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (3 papers), Blood properties and coagulation (2 papers), Tuberculosis Research and Epidemiology (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Hematology (234 citations), Virology (81 citations), Internal Medicine (35 citations), Infectious Diseases (120 citations) and Rheumatology (93 citations). A Loeliger has collaborated with scholars based in Netherlands, Switzerland and United States. Frequent co-authors include F Koller, F Duckert, J. Hers, Sylvia M. Bruisten, Peter Reiss, Charles A. Boucher, F Duckert, Ann Duerr, Mina C. Hosseinipour and Margaret E. Bentley. Their work appears in journals such as Acta Haematologica, Thrombosis and Haemostasis, AIDS, Infection and Contemporary Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.